🇺🇸 CEFOTIAM HYDROCHLORIDE in United States

FDA authorised CEFOTIAM HYDROCHLORIDE on 30 December 1988

Marketing authorisations

FDA — authorised 30 December 1988

  • Application: NDA050601
  • Marketing authorisation holder: TAKEDA
  • Local brand name: CERADON
  • Indication: INJECTABLE — INJECTION
  • Status: approved

Read official source →

FDA

  • Status: approved

CEFOTIAM HYDROCHLORIDE in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is CEFOTIAM HYDROCHLORIDE approved in United States?

Yes. FDA authorised it on 30 December 1988; FDA has authorised it.

Who is the marketing authorisation holder for CEFOTIAM HYDROCHLORIDE in United States?

TAKEDA holds the US marketing authorisation.